Online Wellness Intervention for College Students

Sponsor
University of Pennsylvania (Other)
Overall Status
Recruiting
CT.gov ID
NCT04740411
Collaborator
Indiana University (Other), Ohio State University (Other), University of Missouri, St. Louis (Other)
850
1
2
12
70.9

Study Details

Study Description

Brief Summary

We are evaluating the effects of an online single-session mental health intervention (the Common Elements Toolbox; COMET). To evaluate COMET, we are conducting a randomized controlled trial with college students attending American universities. Students will be randomized to the COMET condition or to a wait-list control condition.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: The Common Elements Toolbox (COMET)
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
850 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
An Online Wellness Intervention for American College Students: Investigating the Efficacy of The Common Elements Toolbox
Actual Study Start Date :
Mar 1, 2021
Anticipated Primary Completion Date :
Mar 1, 2022
Anticipated Study Completion Date :
Mar 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Common Elements Toolbox (COMET)

Behavioral: The Common Elements Toolbox (COMET)
COMET is an online unguided self-help intervention that lasts approximately 60-80 minutes.

No Intervention: Wait-list control condition

Outcome Measures

Primary Outcome Measures

  1. Change in the Patient Health Questionnaire-9 (PHQ-9) [Up to 8 weeks post-intervention]

    Depression questionnaire. Scores range from 0 to 27. Lower scores indicate less depression.

  2. Change in the Generalized Anxiety Disorder Screener-7 (GAD-7) [Up to 8 weeks post-intervention]

    Anxiety questionnaire. Total scores range from 0-21. Lower scores indicate less anxiety.

  3. Change in the Short Warwick-Edinburgh Mental Well-being Scale [Up to 8 weeks post-intervention]

    Subjective Well-being questionnaire. Total scores range from 7 to 35. Higher values indicate higher well-being scores.

  4. Change in items from the PERMA Profiler (positive emotion and negative emotion subscales). [Up to 8 weeks post-intervention]

    Well-being questionnaire with questions related to positive emotion, engagement, relationships, meaning, accomplishment, negative emotion, and health. Scores on each item range from 0 to 5. Lower scores indicate less well-being. We are using a shortened version of this questionnaire with 12 items. We have also modified the items to ask participants about their experiences over the past 48 hours. We predict that our intervention will produce changes in the positive emotion and negative emotion subscales. Each subscale consists of 3 items.

Secondary Outcome Measures

  1. Ratings on the Acceptability of Intervention Measure (AIM) [Immediately after the intervention]

    Questionnaire measuring the acceptability of an intervention. Acceptability refers to the perception that a given treatment is agreeable or satisfactory. The total score ranges from 4 to 20. Higher scores indicate higher acceptability ratings.

  2. Ability to Cope with COVID-19 [Up to 8 weeks post-intervention]

    2 questions related to their ability to cope with stressors over the past two weeks relating to the COVID-19 pandemic. Participants answered these questions on a 7-point Likert Scale, from "strongly disagree" to "strongly agree". Specifically, we asked participants: a) if they have been able to handle lifestyle changes due to the coronavirus and b) if the pandemic has had an extremely negative impact on their life.

  3. Change in Secondary Control [Up to 8 weeks post-intervention]

    We administered three items to assess secondary control, derived from the Secondary Control Scale for Children (Weisz et al., 2010). The items are scored on a 4-point Likert scale, ranging from 0 ("Very false") to 3 ("Very true"). Scores on each item range from 0-4, with higher scores indicating more secondary control.

  4. Change in the Positive and Negative Affect Schedule [Up to 8 weeks post-intervention]

    Questionnaire measuring positive affect and negative affect. Scores on the positive affect subscale range from 10-50, with higher scores representing higher levels of positive affect. Scores on the negative affect subscale range from 10-50, with lower scores representing lower levels of negative affect.

  5. Perceived Utility Ratings [Immediately after the intervention]

    Participants were asked to rate three items relating to the perceived utility of each module. Specifically, we asked participants: How helpful the module was How engaging the module was How much they will continue applying content from the module. Higher scores indicate greater perceived utility.

  6. Change in the Perceived Stress Scale-4 [Up to 8 weeks post-intervention]

    Questionnaire measuring perceived stress. Scores range from 0-16, with higher scores indicating greater stress.

  7. Change in the Gratitude Adjective Checklist [Up to 8 weeks post-intervention]

    Gratitude measure. Three items rated on a 1-5 scale with total scores ranging from 3-15. Higher scores indicate higher levels of gratitude.

  8. Change in the Self-kindness subscale of the Self-Compassion Scale [Up to 8 weeks post-intervention]

    Self-compassion measure. We are using the 5-item self-kindness subscale. Participants will provide values ranging from 1 to 5. These values will be summed to create a total score on this scale ranging from 5 to 25, with higher scores representing higher levels of self-compassion.

  9. Change in Cognitive Restructuring [Up to 8 weeks post-intervention]

    We administered three items to assess cognitive restructuring, derived from the cognitive reappraisal subscale of the Emotion Regulation Questionnaire. Scores range from 3-21, with higher scores representing a higher amount of cognitive restructuring.

  10. Change in items from the Behavioral Activation for Depression Scale [Up to 8 weeks post-intervention]

    Behavioral Activation Measure. We selected 3 items from the BADS to use to assess changes in behavioral activation. The scores for these three items are summed to give a total score from 0-18. Higher scores represent higher levels of behavioral activation.

  11. Beck Hopelessness Scale [Up to 8 weeks post-intervention]

    Hopelessness Questionnaire. Total score ranges from 0 to 4. Higher scores indicate less hope (more hopelessness).

  12. Change in module-specific skills [Up to 8 weeks post-intervention]

    We are administering 4 items designed to detect cognitive or behavioral changes that relate to each intervention module. Cognitive restructuring: "Over the past two weeks, I have been able to manage negative thoughts." Behavior activation: "Over the past two weeks, I have intentionally spent time performing hobbies and activities that make me happy." Gratitude: "Over the past two weeks, I have been able to focus my attention toward noticing and appreciating good things." Self-compassion: "Over the past two weeks, I have been able to treat myself with empathy and compassion." For each item, participants respond using a 7-point scale ranging from strongly disagree to strongly agree. Higher scores indicate favorable cognitions and behaviors related to each construct.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • At least 18 years old and a student at a participating university. Access to the internet.
Exclusion Criteria:
  • Cannot have participated in a previous version of COMET.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Pennsylvania Philadelphia Pennsylvania United States 19104

Sponsors and Collaborators

  • University of Pennsylvania
  • Indiana University
  • Ohio State University
  • University of Missouri, St. Louis

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT04740411
Other Study ID Numbers:
  • 844589
First Posted:
Feb 5, 2021
Last Update Posted:
May 14, 2021
Last Verified:
May 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 14, 2021